Thorough ECG (Electrocardiogram) and Drug Interaction Study With Anetumab Ravtansine and Itraconazole

Clinical trial NCT02824042 · COMPLETED

Trial details

NCT number: NCT02824042
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Medical Oncology

Start date: 2016-09-07
Primary completion: 2018-06-27
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.